Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

S-1 adjuvant chemotherapy for advanced gastric cancer

Nature Clinical Practice Oncology volume 5, pages 370–371 (2008)Cite this article

boxed-textSakuramoto S et al. (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810–1820

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kamangar F et al. (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137–2150

    Article  Google Scholar 

  2. Macdonald JS et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725–730

    Article  CAS  Google Scholar 

  3. Cunningham D et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11–20

    Article  CAS  Google Scholar 

  4. Bonenkamp JJ et al. for the Dutch Gastric Cancer Group (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908–914

    Article  CAS  Google Scholar 

  5. Cuschieri A et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative group. Br J Cancer 79: 1522–1530

    Article  CAS  Google Scholar 

  6. Cunningham D et al. (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36–46

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Gastrointestinal Oncology, Memorial Sloan–Kettering Cancer Center, 275 York Avenue, New York, NY 10021, USA kelsend@mskcc.org

Authors and Affiliations

  1. D Kelsen is Edward Gordon Chair in Medical Oncology and Chief of the Gastrointestinal Oncology service at Memorial Sloan–Kettering Cancer Center, New York, NY, USA.,

    David Kelsen

Authors
  1. David Kelsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelsen, D. S-1 adjuvant chemotherapy for advanced gastric cancer. Nat Rev Clin Oncol 5, 370–371 (2008). https://doi.org/10.1038/ncponc1152

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1152

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing